First, we used our novel Akt-FRET biosensor mouse to measure and map AKT activity in the native tumor context of PTEN-deficient pancreatic ductal adenocarcinoma (PDAC) tumors. The gene discussed is AKT1; the disease is pancreatic ductal adenocarcinoma.